Clonidine vs Klonopin: Not the Same Drug, and Why Clonidine Shows Up in Opioid Detox

Is clonidine a benzodiazepine?

No. Clonidine is a centrally acting alpha-2 adrenergic agonist, a blood pressure drug. It lowers the brain’s output of norepinephrine, the fight-or-flight signal, which slows the heart, lowers blood pressure, and causes drowsiness. Klonopin is the brand name of clonazepam, a benzodiazepine that works on GABA-A receptors. The two share a first syllable and some sedation. Nearly everything else is different.

Clonidine vs Klonopin: why the names get mixed up

The confusion is not just a search-bar problem. The Institute for Safe Medication Practices keeps a list of confused drug names drawn from real medication errors, and it lists cloNIDine with both clonazePAM and KlonoPIN. The odd capitals are tall-man lettering, which pharmacies use to make the difference jump off a label.

“Clonopine” is not a drug. It is a common misspelling of Klonopin, sometimes blended with clonidine, and it is worth knowing which one you meant before you look up a dose, an interaction, or a withdrawal plan. Swapping them in either direction is a real problem: clonidine in place of clonazepam leaves a person on a benzodiazepine suddenly without it, and clonazepam in place of clonidine leaves blood pressure uncovered. If the bottle’s name does not match what the prescriber said, ask the pharmacist before taking it.

Clonidine other names

• Catapres: immediate-release tablets, for high blood pressure (the brand is discontinued; generic clonidine tablets remain available)
• Catapres-TTS: a weekly skin patch, for high blood pressure
• Nexiclon XR: extended-release tablets, for high blood pressure
• Kapvay (brand discontinued) and generic clonidine extended-release tablets: for ADHD, alone or with a stimulant
• Onyda XR: an extended-release liquid for ADHD in children 6 and older
• Duraclon: an epidural injection used with opioids for severe cancer pain

On clonidine classification: it is a central alpha-2 agonist and an antihypertensive. It is not a benzodiazepine, not an opioid, not a barbiturate, and not a scheduled drug under federal law.

Is clonidine addictive?

Not in the usual sense. The Kapvay label states that it is not a controlled substance and has no known potential for abuse or dependence. Two caveats keep that from being the whole story.

First, the body adapts to clonidine, and stopping it abruptly causes a withdrawal reaction, covered below. Second, clonidine misuse among people who use opioids is documented. In a 1998 survey at three methadone programs, applicants mostly took non-prescribed clonidine to ease opioid withdrawal, while clonidine-misusing patients already in treatment took it mainly for its psychoactive effects, including how it interacts with methadone, and most of them considered it addictive. Earlier case reports described clonidine misuse alone or with diazepam. Clonidine with opioids or other sedatives deepens sedation and can slow the heart and breathing.

Clonidine for withdrawal: why it shows up in opioid detox

Much of opioid withdrawal is a surge of norepinephrine. Regular opioid use pushes a brain region called the locus coeruleus to work harder against the drug; when the opioid is gone, those cells release excess norepinephrine, which NIDA’s journal Science & Practice Perspectives ties to the jitters, anxiety, cramps, and diarrhea. Clonidine turns that signal down. It is not an opioid and does not treat opioid use disorder itself, and detox teams pair it with other medicines for pain, nausea, diarrhea, and sleep.

Clonidine is not FDA-approved for opioid withdrawal; it is used off-label. Its cousin lofexidine, sold as Lucemyra, is: the Lucemyra label approves it, since 2018, to ease opioid withdrawal symptoms during an abrupt stop, for up to 14 days, followed by a two-to-four-day taper. The ASAM national practice guideline for opioid use disorder treats both as safe options for withdrawal symptoms and as less effective than methadone or buprenorphine.

That last point is the one families should hear. A clonidine-only detox gets someone through the physical withdrawal and leaves them with reduced opioid tolerance. The Lucemyra label says it directly: people who complete opioid discontinuation are at increased risk of fatal overdose if they use again, and it is not a treatment for opioid use disorder. ASAM rates buprenorphine or methadone as more effective than alpha-2 agonists and does not recommend withdrawal management on its own, without ongoing treatment. Anyone leaving an opioid detox should leave with naloxone. Our opioid detox guide explains the options, and the page on precipitated withdrawal explains why the timing of a first buprenorphine dose matters.

The side effects that limit it

The same action that calms withdrawal lowers blood pressure and pulse. Dizziness on standing, fainting, a slow heart rate, drowsiness, and dry mouth are the common problems, and the Lucemyra label tells staff to check vital signs before dosing. The ASAM guideline describes the two drugs as similarly effective, with low blood pressure less frequent on lofexidine.

Clonidine withdrawal symptoms

This is the danger people miss. Clonidine has to be tapered. The clonidine tablet label warns that sudden cessation has caused nervousness, agitation, headache, and tremor, accompanied or followed by a rapid rise in blood pressure. Rare cases of hypertensive encephalopathy, stroke, and death have been reported after clonidine withdrawal.

• Nervousness, agitation, anxiety, restlessness
• Headache
• Tremor, sweating, flushing
• Racing or pounding heart
• Insomnia
• Nausea
• Blood pressure back at or above where it was before treatment

The risk is higher at higher doses and in people also taking a beta-blocker; the label says the beta-blocker should be stopped several days before clonidine is tapered. Children are a special case, because a stomach bug that stops them keeping tablets down can become an abrupt stop.

Clonidine withdrawal timeline

The study, published in The Lancet in 1977, was small, six patients, and its symptoms were most prominent at doses above 1 mg a day. A 2005 review of antihypertensive withdrawal describes the full syndrome as rare at standard doses. Rare is still a reason to taper.

How long does clonidine stay in your system?

Clonidine’s half-life is 12 to 16 hours, so, as a rough estimate at five half-lives, most of it clears within about three days. Severe kidney disease can stretch the half-life to 41 hours. Extended-release forms release the drug more slowly, and the Kapvay label carries the same warning about rebound blood pressure after an abrupt stop.

Stopping clonidine safely

Never stop clonidine abruptly. The immediate-release label tells prescribers to reduce the dose gradually over two to four days; the ADHD extended-release labels call for reductions of no more than 0.1 mg every three to seven days. A prescriber sets the schedule. If you have run out, call the prescriber or pharmacy the same day rather than waiting it out.

Klonopin, clonidine, and the detox that each one needs

Klonopin withdrawal has its own seizure risk. Clonazepam is long-acting, so symptoms often start two to seven days after the last dose and can include seizures. It needs a slow, prescriber-led taper, and for high doses a supervised start. Our Klonopin guide covers the half-life, the boxed warning, and how the taper is paced; the benzodiazepine detox guide covers supervised tapers in New Jersey.

Clonidine cannot replace a benzodiazepine in that setting. The ASAM alcohol withdrawal guideline allows alpha-2 agonists such as clonidine as an add-on to benzodiazepines for racing heart, other signs of autonomic overactivity, and anxiety that benzodiazepines alone have not controlled, and says they should not be used alone to prevent or treat withdrawal seizures or delirium. Taking clonidine and clonazepam together is sometimes prescribed; both are sedating, and the clonidine label warns that it can intensify the effects of alcohol and other sedating drugs.

In New Jersey

Under New Jersey law P.L.2017, c.28, fully insured New Jersey plans and the State Health Benefits and School Employees’ plans cannot require prior authorization for the first 180 days per plan year of in-network treatment your own physician, psychologist or psychiatrist finds medically necessary, and cannot run concurrent or retrospective medical-necessity review for the first 28 days of an in-network inpatient stay. Self-funded employer plans, Medicare and Medicaid are not covered by that rule, so verify with the plan. NJ FamilyCare covers the substance use continuum, from withdrawal management through outpatient care, including medications for opioid use disorder, with the level of care set by ASAM criteria and, for some levels, prior authorization. Our NJ Medicaid guide and Horizon guide go plan by plan.

ReachNJ at 1-844-732-2465 is the state’s free treatment line, and the IME Addictions Access Center at 1-844-276-2777 screens NJ FamilyCare and uninsured residents and refers them to treatment. Periscope Behavioral Health, which publishes this site, is opening a medical detox in Hammonton, Atlantic County, expected Summer 2027. Until then, the admissions line of our publisher at (888) 313-3583 can talk through options in New Jersey and Florida, including facilities Periscope operates. What a plan covers depends on the plan and the facility’s network status. For a mental health crisis, call or text 988.